Not an SEC registrant

Simcere Zaiming, Inc.

Customers

None disclosed

Suppliers

1 disclosed

Latest period

Dec 31, 2025

10-K filed 2026-03-05

Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available) or federal dollars obligated. Each side is scaled on its own; dashed outlines are named without a figure. Click a band to open its source.

Suppliers 1

Companies that disclose Simcere Zaiming, Inc. as a major customer, as a share of their own revenue. 1 active, 0 lapsed.

Company	% of their revenue	Est. $ from Simcere Zaiming, Inc.	Period	Trend	Status	Source
NXTC NextCure, Inc.	Named	—	FY 2025-12-31	—	Active	10-K 2026-03-05
In connection with the License Agreement, the Company also entered into a Subscription Agreement (the “Subscription Agreement”) pursuant to which the Company issued and sold to Simcere Zaiming, Inc. (“Simcere Zaiming”), a Delaware corporation and an affiliate of Zaiming, in a private placement, an aggregate of 338,636 shares (the “Shares”) of the common stock of the Company, par value $0.001 per share, at a price of approximately $5.904 per Share for an aggregate purchase price of $2.0 million. 10-K filed 2026-03-05 Period FY 2025-01-01 to 2025-12-31Accession 0001104659-26-024137

Alerts are coming

Get an email when Simcere Zaiming, Inc.'s disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.